
Articles
-
5 days ago |
journals.lww.com | Catlin Nalley
By Catlin NalleyThe Phase III SERENA-6 trial demonstrated that switching to camizestrant in combination with a CDK4/6 inhibitor—guided by the emergence of an ESR1 mutation (ESR1m) during first-line aromatase inhibitor plus CDK4/6 inhibitor therapy—led to a statistically significant and clinically meaningful improvement in progression-free survival (PFS) for patients with hormone receptor–positive, HER2-negative (HR+/HER2–) advanced breast cancer.
-
3 weeks ago |
reviewofoptometry.com | Catlin Nalley
In the ever-evolving landscape of optometric practice, the definition of clinical specialization continues to expand. While subspecialties like retina, pediatrics and cornea have long been established pillars of the profession, a growing number of optometrists are charting a new course—one that embraces a more holistic, preventative and lifestyle-oriented approach to patient care. At the heart of this movement is a rising interest in wellness and nutrition.
-
1 month ago |
reviewofoptometry.com | Catlin Nalley
In the April 2025 issue of Review of Optometry—the magazine's 12th annual cornea report—learn effective strategies for managing herpetic keratitis, delve into advanced imaging techniques for early detection of keratoconus and get expert tips for specializing in advanced corneal care. Check out the other articles featured in this issue:My Patient Has Herpetic Keratitis… Now What?
-
2 months ago |
reviewofoptometry.com | Catlin Nalley
Myopia is on the rise globally, with projections indicating that half of the world’s population will be affected by 2050. As prevalence increases, so does the need for specialized care to slow its progression and mitigate long-term ocular health risks. Optometrists who embrace myopia management have a unique opportunity to address a growing public health challenge while expanding their clinical expertise and practice offerings through evidence-based interventions that make a lasting impact.
-
Feb 15, 2025 |
reviewofoptometry.com | Catlin Nalley
Specialty care plays a critical role in the evolving field of optometry. As primary eyecare providers, optometrists are in a position to identify and address complex visual and ocular health issues that can strongly impact patients’ lives. Developing a niche specialty enhances the level of care provided and helps build a practice that stands out.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 23
- Tweets
- 3
- DMs Open
- No

RT @GeorgeSledge51: FELINE trial (my favorite trial name of the meeting) compares neoadjuvant letrozole plus ribociclib vs letrozole plus p…

#BeatAML Master Trial highlights the power of precision medicine for older patients with AML https://t.co/2Bk4cz90La #ASH19 @LLSusa @OncologyTimes